Works by Chen, M.-H.


Results: 135
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 5, p. 1938, doi. 10.1007/s12325-024-02822-z
    By:
    • Salles, Gilles;
    • Chen, Jenny M. H.;
    • Zhang, Ina;
    • Kerbauy, Fabio;
    • Wu, James J.;
    • Wade, Sally W.;
    • Nunes, Ana;
    • Feng, Chaoling;
    • Kloos, Ioana;
    • Peng, Weimin;
    • Snider, Julia T.;
    • Maciel, Dylan;
    • Chan, Keith;
    • Keeping, Sam;
    • Shah, Bijal
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 1, p. 14, doi. 10.1080/10428194.2023.2268228
    By:
    • Hess, Georg;
    • Dreyling, Martin;
    • Oberic, Lucie;
    • Gine, Eva;
    • Zinzani, Pier Luigi;
    • Linton, Kim;
    • Vilmar, Adam;
    • Jerkeman, Mats;
    • Chen, Jenny M. H.;
    • Ohler, Anke;
    • Stilgenbauer, Stephan;
    • Thieblemont, Catherine;
    • Lambert, Jonathan;
    • Zilioli, Vittorio Ruggero;
    • Sancho, Juan-Manuel;
    • Jimenez-Ubieto, Ana;
    • Fischer, Luca;
    • Eyre, Toby A.;
    • Keeping, Sam;
    • Park, Julie E.
    Publication type:
    Article
    47
    48
    49
    50